(Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical validation study ever conducted. This milestone strengthens the ...

SAN ANTONIO, March 17, 2026--bioAffinity Technologies' new patient case study demonstrates the benefit of CyPath Lung in ...

Imagine you go to the healthcare provider because you have a bad cough, or maybe you fell and hurt your ribs.

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

As air quality index (AQI) levels increase, breathlessness has become the new normal, often blamed on seasonal smog. In cities where a thick grey canopy has become part of the permanent skyline, a ...

Minimally invasive technology enables earlier detection and faster treatment of lung cancer Broward Health Medical Center announced the acquisition of the Ion™ Endoluminal System. This ...

The stock jumped on heavy volume after a positive update tied to its AI-driven lung cancer screening test.

When Dan Hannon, 72, received guidance to have part of a lung taken out whether nodules were cancerous or not, he wanted a second opinion to see if he would indeed live the rest of his life without a ...

On Wednesday, March 25, Decatur resident and lung cancer survivor, La’Kesha Johnson, will travel to Washington, D.C., to meet with her members of Congress for the American Lung Association’s 11th ...

A young woman steps nervously into a makeshift screening tent. Inside, a small tripod-mounted thermal camera waits. Asked to place her hands behind her head, sh ...